Generalizability of trial results to elderly Medicare patients with advanced solid tumors (Alliance 70802)
Lamont EB, Schilsky RL, He Y, Muss H, Cohen HJ, Hurria A, Meilleur A, Kindler HL, Venook A, Lilenbaum R, Niell H, Goldberg RM, Joffe [...]
Minimize toxicity or preserve efficacy? A delicate trade-off in the management of older patients with lung cancer
Owonikoko TK, Ramalingam SS. J Clin Oncol. 2015 Feb 20;33(6):534-6. doi: 10.1200/JCO.2014.59.5033. Epub 2015 Jan 12. (Journal of Clinical Oncology)
Tumor marker usage and medical care costs among older early-stage breast cancer survivors
Ramsey SD, Henry NL, Gralow JR, Mirick DK, Barlow W, Etzioni R, Mummy D, Thariani R, Veenstra DL. J Clin Oncol. 2015 Jan 10;33(2):149-55. doi: [...]
Polypharmacy: Geriatric Oncology Evaluation Should Become Mainstream
Lichtman SM. J Clin Oncol. 2015 Mar 23. pii: JCO.2014.60.3548. [Epub ahead of print] (Journal of Clinical Oncology)
Ageism in the undertreatment of high-risk prostate cancer: how long will clinical practice patterns resist the weight of evidence?
Shumway DA, Hamstra DA. J Clin Oncol. 2015 Mar 1;33(7):676-8. doi: 10.1200/JCO.2014.59.4093. Epub 2015 Jan 5. (Journal of Clinical Oncology)
Prognostic Significance of NPM1 Mutations in the Absence of FLT3-Internal Tandem Duplication in Older Patients With Acute Myeloid Leukemia: A SWOG and UK National Cancer Research Institute/Medical Research Council Report.
Ostronoff F, Othus M, Lazenby M, Estey E, Appelbaum FR, Evans A, Godwin J, Gilkes A, Kopecky KJ, Burnett A, List AF, Fang M, Oehler [...]
A review of the management of elderly patients with non-small-cell lung cancer.
Blanco R, Maestu I, de la Torre MG, Cassinello A, Nuñez I. Ann Oncol. 2015 Mar;26(3):451-63. doi: 10.1093/annonc/mdu268. Epub 2014 Jul 24. (Annals of Oncology)
Evaluation of a pharmacist-led medication assessment used to identify prevalence of and associations with polypharmacy and potentially inappropriate medication use among ambulatory senior adults with cancer.
Nightingale G, Hajjar E, Swartz K, Andrel-Sendecki J, Chapman A. J Clin Oncol. 2015 May 1;33(13):1453-9. doi: 10.1200/JCO.2014.58.7550. Epub 2015 Mar 23. (Pubmed)
Screening for predictors of adverse outcome in onco-geriatric surgical patients: A multicenter prospective cohort study.
Huisman MG, Audisio RA, Ugolini G, Montroni I, Vigano A, Spiliotis J, Stabilini C, de Liguori Carino N, Farinella E, Stanojevic G, Veering BT, Reed [...]
Impact of age and medical comorbidity on adjuvant treatment outcomes for stage III colon cancer: a pooled analysis of individual patient data from four randomized, controlled trials.
Haller DG, O'Connell MJ, Cartwright TH, Twelves CJ, McKenna EF, Sun W, Saif MW, Lee S, Yothers G, Schmoll HJ. Ann Oncol. 2015 Apr;26(4):715-24. doi: 10.1093/annonc/mdv003. [...]
Different adjuvant chemotherapy regimens in older breast cancer patients?
Wildiers H., Brain E. Ann Oncol (2015) 26 (4): 613-615. doi: 10.1093/annonc/mdv015 First published online: January 18, 2015 (Annals of Oncology)
Adjuvant chemotherapy for elderly patients with stage I non-small-cell lung cancer ≥4 cm in size: an SEER-Medicare analysis
Malhotra J, Mhango G, Gomez JE, Smith C, Galsky MD, Strauss GM, Wisnivesky JP. Ann Oncol. 2015 Apr;26(4):768-73. doi: 10.1093/annonc/mdv008. Epub 2015 Jan 18. (Pubmed)
